The government is stepping up its efforts to boost the capability and capacity of the nation's bio-chem defense and pandemic vaccines and therapeutics industry. To support this goal, additional funding and incentives are being pushed on several fronts. Congress appropriated over $3.8 billion for Fiscal Year 2006 for pandemic influenza preparedness, including the purchase of vaccines and therapeutics, and targeted efforts to help accelerate the research and development of advanced technologies and medical countermeasures
DISCLAIMER: Our aim is to continuously provide our
progressive audience with an open and interactive medium to view
and share relevant,
beneficial and interesting "career, economic, lifestyle and
networking" listings, ads, content and resources.
While the above information may be accurate and viable, the role
of Minority Professional Network, Inc. (MPN) is
strictly as a communications medium, and we do not
accept any responsibility for
cancellation, changes, errors, omissions, inconveniences, or any other form
of liability for any content
displayed or disseminated via our web sites, or e-marketing or social media
promotional services.
If there are any
doubts, we
encourage you to conduct additional research or contact the listed host or responsible entity.
CLICK HERE to inform us about any ads, listings or content
which appear to be
inappropriate,
fraudulent or misleading, or inconsistent with our theme and focus.